Both in Pharmaceuticals
Faeth Therapeutics vs Capricor Therapeutics
Over the past year FTH returned −47.5% and CAPR returned −1.6%; their daily moves had a correlation of 0.53.
FTH −47.5% CAPR −1.6%Growth of $1, one year, split-adjusted
| Metric | FTH | CAPR |
|---|---|---|
| Price | $19.65 | $8.24 |
| Market cap | $507.8M | $479.1M |
| Today | +2.18% | +13.81% |
| 1 month | −27.5% | +5.9% |
| 6 months | — | −75.0% |
| Year to date | — | −71.4% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $186.4M | $237.9M |
| Dividend yield | — | — |
| Volatility (60d) | — | 143.5% |
| Short % of float | 20.5% | 48.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).